(2R,3S)-3-isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine

Catalog No. :
ACWVQK064
CAS No. :
1699751-03-5
Molecular Formula :
C19H20N2S
Molecular Weight :
308.13

IUPAC Name:(2R,3S)-3-isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine

(2R,3S)-3-isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$126.00Login to see priceIn stockInquiry
250mg98%$249.00Login to see priceIn stockInquiry
1g98%$903.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S)-3-isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine
IUPAC Name(2R,3S)-3-isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine
MDL No.MFCD29037150
Molecular FormulaC19H20N2S
Molecular Weight308.13
SMILESCC([C@H]1CN2C3=CC=CC=C3SC2=N[C@H]1C4=CC=CC=C4)C
InChI KeyRPBRMANNSNGNFS-QAPCUYQASA-N
Synonym2H-Pyrimido[2,1-b]benzothiazole, 3,4-dihydro-3-(1-methylethyl)-2-phenyl-, (2R,3S)-;(2R,3S)-3-Isopropyl-2-phenyl-3,4-dihydro-2H-pyrimido[2,1-b][1,3]benzothiazole;(2R,3S)-3-Isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine
CAS No.1699751-03-5
PubChem CID122360908

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P271-P280

Synthetic Route by SureRoute

1. ACWVQK064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWVQK064 route product structure diagram
    ACWVQK0641699751-03-5 In Stock
Inquiry

2. ACWVQK064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWVQK064 route product structure diagram
    ACWVQK0641699751-03-5 In Stock
Inquiry

Comments (0)